Results 311 to 320 of about 238,614 (342)
Some of the next articles are maybe not open access.
Interleukin-1 receptor antagonist: Discovery, structure and properties
Progress in Growth Factor Research, 1990Interleukin-1 receptor antagonist (IL-1ra) is a recently-described member of the IL-1 family. This unique human protein has 30% amino acid sequence homology to IL-1 beta and binds to human types I and II IL-1 receptors without apparent cellular activation.
openaire +3 more sources
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-vornhagen +2 more
exaly
Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)
2019Deficiency of the interleukin-1 receptor antagonist IL-1Ra (DIRA) is a very rare and severe autoinflammatory disease associated with loss of function mutations in the IL1RN gene. Inflammation results from unopposed signaling by IL-1α and IL-1β. DIRA presents mostly in the neonatal period with systemic inflammation and characteristic skin pustulosis and
openaire +2 more sources
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Interleukin-1 receptor antagonist reduces mortality from endotoxin shock
Nature, 1990K. Ohlsson +4 more
semanticscholar +1 more source
A review of cancer immunotherapy toxicity
Ca-A Cancer Journal for Clinicians, 2020Lucy Boyce Kennedy
exaly